NCT01636908 2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA Completed
Clinical Trials
8 trialsNCT02142036 2019-03-13
MetAction
Oslo University Hospital
Phase 2 Completed
NCT01290354 2017-11-13
Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer
GlaxoSmithKline
Phase 1 Completed
NCT01332396 2017-04-26
Drug Use Investigation for TYKERB Tablet (All Case Investigation)
Novartis
Completed
NCT01328054 2016-06-08
A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
GlaxoSmithKline
Phase 4 Completed
NCT01087983 2015-11-11
Lapatinib With Sirolimus or Metformin
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00975988 2014-10-27
Regulatory TYKERB® Tablets PMS
GlaxoSmithKline
Completed
NCT00259987 2009-05-18
Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
GlaxoSmithKline
Phase 2 Completed